Search Close Search
Page Menu

Muthalagu Ramanathan, MD

Research Focus - Multiple Myeloma Clinical Research

  • Bringing in novel treatment clinical trials in multiple myeloma such as CAR T cells and bispecific antibodies
  • Using maintenance daratumumab in addition to Revlimid (lenalidomide) after stem cell transplant

Representative Publication

Wang X, Vogt B, Shanahan L, et al. Elotuzumab-based maintenance therapy following autologous stem cell transplant in multiple myeloma deepens post-transplant responses. Blood Cells Mol Dis. 2020;85:102482.

Read Publication

More Publications